Add to ORKGWe present a device platform for point-of-care testing of whole blood samples. It enables the determination of the viral load of blood on a processor-controlled device platform. For the analysis process two disposable cartridges carrying the fluidic and a media module are placed together in one device platform. In order to verify the operational capability of the device the following sample viruses were selected for the project and hoarded in two bio banks: Cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV) 1 and 2 and Epstein-Barr virus (EBV). Copyrigh
The ability of conduct self-testing of diseases from a single drop of blood in a point-of-care setti...
The development of technologies that enable early and accurate diagnosis is critical to the manageme...
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of earl...
Biosensor technologies have enormous potential in the field of biomedical diagnostics. Despite this,...
In recent years, microfluidic lab-on-a-chip devices have made tremendous progress. Many new features...
Point-of-care diagnostics and therapeutics have the potential to radically change and improve the wa...
International audienceAccording to the Global Burden of Diseases, chronic viral hepatitis B and C ar...
Performing medical diagnosis in microfluidic devices could scale down laboratory functions and reduc...
We demonstrate a proprietary lab-on-chip/mu TAS technology platform for a regulatory grade portable ...
CONSPECTUS: Reliable, inexpensive, and rapid diagnostic tools are essential to control and prevent t...
Rapid and timely diagnosis of infectious diseases is a critical determinant of clinical outcomes and...
Point-Of-Care (POC) testing has advanced to more affordable and rapid alternatives by adapting conve...
Medical diagnostics contributes a large portion of both time and resources in the timeline of medica...
Microfluidic systems can allow for the processing of a small volume of sample resulting in a portabl...
We report a biosensing platform for viral load measurement through electrical sensing of viruses on ...
The ability of conduct self-testing of diseases from a single drop of blood in a point-of-care setti...
The development of technologies that enable early and accurate diagnosis is critical to the manageme...
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of earl...
Biosensor technologies have enormous potential in the field of biomedical diagnostics. Despite this,...
In recent years, microfluidic lab-on-a-chip devices have made tremendous progress. Many new features...
Point-of-care diagnostics and therapeutics have the potential to radically change and improve the wa...
International audienceAccording to the Global Burden of Diseases, chronic viral hepatitis B and C ar...
Performing medical diagnosis in microfluidic devices could scale down laboratory functions and reduc...
We demonstrate a proprietary lab-on-chip/mu TAS technology platform for a regulatory grade portable ...
CONSPECTUS: Reliable, inexpensive, and rapid diagnostic tools are essential to control and prevent t...
Rapid and timely diagnosis of infectious diseases is a critical determinant of clinical outcomes and...
Point-Of-Care (POC) testing has advanced to more affordable and rapid alternatives by adapting conve...
Medical diagnostics contributes a large portion of both time and resources in the timeline of medica...
Microfluidic systems can allow for the processing of a small volume of sample resulting in a portabl...
We report a biosensing platform for viral load measurement through electrical sensing of viruses on ...
The ability of conduct self-testing of diseases from a single drop of blood in a point-of-care setti...
The development of technologies that enable early and accurate diagnosis is critical to the manageme...
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of earl...